文献速递头颈外科

头颈癌治疗后影像监测的费用分析

Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

该单机构回顾性经济评价研究纳入136例新诊断头颈癌患者,评估监测期影像检查模式及费用。无症状患者年均4次、年均费用9600美元。复发患者年均检查次数和费用均高于无病患者。

要点

  • 头颈癌治疗后监测期影像检查次数和费用较高,多数超出NCCN指南推荐。
  • 无症状患者年均接受4次影像检查,年均费用约9600美元。

核心结论

  • 许多头颈癌患者在治疗后接受的影像监测超出NCCN指南推荐,无症状患者的影像费用负担需与常规影像的获益权衡。

主要发现

  • 无症状患者每年平均接受4次(标准差3)影像检查,年均费用9600美元(标准差5900)。

关键数值与推荐

  • NCCN指南推荐头颈癌治疗后6个月内进行影像检查,仅在患者有症状或体格检查异常时推荐进一步影像检查。

临床怎么用

  • 临床应遵循NCCN指南,避免对无症状头颈癌治疗后患者进行超出推荐的常规影像监测,以控制费用负担。

局限性

  • 本研究为单机构回顾性经济评价,样本量有限,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The National Comprehensive Cancer Network recommends imaging within 6 months after treatment for head and neck cancer (HNC). Further imaging is recommended only if the patient has symptoms or abnormal findings on physical examination. However, in many instances, asymptomatic patients continue to have imaging evaluations. OBJECTIVES: To assess practice patterns in surveillance imaging in patients with HNC and evaluate the costs associated with these imaging practices. DESIGN, SETTING, AND PARTICIPANTS: This single-institution retrospective economic evaluation study screened 435 patients to identify patients newly diagnosed with head and neck mucosal and salivary gland malignant tumors between January 1, 2010, and December 31, 2016. Data analyses were performed from October 25, 2018, to November 24, 2020. EXPOSURE: Imaging practice patterns. MAIN OUTCOMES AND MEASURES: Number and costs of imaging studies during the surveillance period for all patients, patients who remained disease free, and patients who developed recurrence. RESULTS: A total of 136 patients (mean [SD] age at diagnosis, 62 [14] years; 84 [61.8%] male; 106 [77.9%] White) with HNC were included in the study. The oropharynx was the most common subsite (64 [47.1%]), most HNCs were stage IVA (62 [45.6%]), and most patients received definitive radiation-based treatment (71 [52.2%]). During the median surveillance period of 3.2 years (range, 0.3-6.8 years), a mean (SD) of 14 (10) imaging studies were performed for all patients, with a mean (SD) total cost of $36 800 ($24 500). In patients who remained disease free, a mean (SD) of 13 (10) imaging studies were performed during the surveillance period, with a mean (SD) total cost of $35 000 ($21 700). Patients who lacked symptoms had a mean (SD) of 4 (3) studies performed per year, resulting in a mean cost of $9600 ($5900) per year. Patients who developed recurrence had more studies per year of follow-up (mean difference, 5.0; 95% CI, 3.4-6.6) and higher associated mean costs (mean difference, $10 600; 95% CI, $6100-$15 000) than patients who remained disease free. CONCLUSIONS AND RELEVANCE: In this economic evaluation study, many patients treated for HNCs received imaging studies beyond what is recommended by National Comprehensive Cancer Network guidelines. These findings suggest that the cost burden of imaging in the asymptomatic patient needs to be considered against the value obtained from routine imaging in this current health care environment.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nocon CC, Kennedy A, Jaffe J, et al. Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33983375. doi:10.1001/jamaoto.2021.0835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。